14.05.19: Kepler Cheuvreux One-Stop-Shops-Tour, Copenhagen, Scandinavia
Kepler Cheuvreux One-Stop-Shops-Tour, Copenhagen, ScandinaviaLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
15.05.19: Kepler Cheuvreux One-Stop-Shops-Tour, Stockholm, Scandinavia
Kepler Cheuvreux One-Stop-Shops-Tour, Stockholm, ScandinaviaLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
04.06.19: Bernstein Consumer Health & Nutrition Seminar, London, UK
Bernstein Consumer Health & Nutrition Seminar, London, UKLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
06.06.19: Barclays European Select Conference, Sonoma - California, USA
Barclays European Select Conference, Sonoma - California, USALink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
06.06.19: Deutsche Bank Access Germany Conference, Berlin, Germany
Deutsche Bank Access Germany Conference, Berlin, GermanyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
26.06.19: Deutsche Bank, Issuer & Investor Bond Forum; London, UK
Deutsche Bank, Issuer & Investor Bond Forum; London, UKLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
27.06.19: Deutsche Bank, Issuer & Investor Bond Forum; Frankfurt, Germany
Deutsche Bank, Issuer & Investor Bond Forum; Frankfurt, GermanyLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - May 2, 2019 Category: Pharmaceuticals Source Type: news
29.04.19: Not intended for U.S. and UK Media
U.S. FDA accepts new drug application and grants priority review for darolutamidemehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 29, 2019 Category: Pharmaceuticals Source Type: news
29.04.19: Not intended for U.S. and UK Media
Study reaffirms safety and efficacy profile of Xarelto™ for the prevention of stroke in patients with atrial fibrillationFirst results from RELOADED, an observational study in the EU, indicate that non-vitamin-K oral anticoagulants (NOACs) like Xarelto provide a benefit in renal preservation over time when compared to the vitamin-K antagonist (VKA) phenprocoumon / The data from the comparative effectiveness study in Germany confirm an improved safety outcome and comparable effectiveness for Xarelto compared with phenprocoumon in patients with non-valvular atrial fibrillation (NVAF), including those with renal insuffi...
Source: Bayer IR Newsfeed: Events - April 28, 2019 Category: Pharmaceuticals Source Type: news
27.04.19: After Annual Stockholders' Meeting votes to not ratify Board of Management's actions:
Bayer's Supervisory Board unanimously stands behind Board of Managementmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 27, 2019 Category: Pharmaceuticals Source Type: news
26.04.19: CEO Werner Baumann at the Annual Stockholders' Meeting of Bayer AG:
"We made great progress - both operationally and strategically"Bayer now the leader in agriculture / Lawsuits and first verdicts concerning glyphosate weigh on company / Sales and earnings increased in 2018 / Proposed dividend of 2.80 euros marks record payout by Bayer / Successful start to fiscal 2019 - outlook confirmedmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 26, 2019 Category: Pharmaceuticals Source Type: news
25.04.19: First quarter of 2019:
Bayer: strong operational start to the yearGroup sales increase 4.1 percent (Fx & portfolio adj.) to 13.015 billion euros / EBITDA before special items advances by 44.6 percent to 4.188 billion euros / Crop Science posts substantial sales and earnings gains following the acquisition / Pharmaceuticals shows encouraging sales and earnings growth / Consumer Health below the prior-year quarter, full-year outlook confirmed / Net income declines as expected by 36.5 percent to 1.241 billion euros, held back by special items related to the acquisition and restructuring / Core earnings per share increase 13.8 percent to 2.55 euros ...
Source: Bayer IR Newsfeed: Events - April 25, 2019 Category: Pharmaceuticals Source Type: news
01.08.19: Crop Science Summer Technology Showcase Day 1 (Chesterfield Research Campus), St. Louis, MO, U.S.A.
Crop Science Summer Technology Showcase Day 1 (Chesterfield Research Campus), St. Louis, MO, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 23, 2019 Category: Pharmaceuticals Source Type: news
02.08.19: Crop Science Summer Technology Showcase Day 2 (Jerseyville Research Farm), St. Louis, MO, U.S.A.
Crop Science Summer Technology Showcase Day 2 (Jerseyville Research Farm), St. Louis, MO, U.S.A.Link to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 23, 2019 Category: Pharmaceuticals Source Type: news
15.04.19: Start of Quiet Period
Start of Quiet PeriodLink to website (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - April 11, 2019 Category: Pharmaceuticals Source Type: news
